update deskSchools & Higher Education

Israeli researchers convert human skin cells into placenta cells

The study could lead to treatments for fertility issues and pregnancy complications.

Placenta multinucleated cells. Credit: Moriyah Naama/Buganim Lab.
Placenta multinucleated cells. Credit: Moriyah Naama/Buganim Lab.

In a breakthrough for understanding fertility and pregnancy issues, Israeli scientists have converted human skin cells into functional human placenta cells.

Professor Yossi Buganim and his research team at the Faculty of Medicine at the Hebrew University of Jerusalem published their study in the peer-reviewed journal Nature Communications.

The placenta is an organ that develops in the uterus during pregnancy and provides nutrients and oxygen to a baby. The umbilical cord is attached to the placenta. The breakthrough research provides an unlimited supply of cells for studying the function of the placenta.

This breakthrough could open up new avenues to solving pregnancy problems by using skin cells from women with pregnancy complications that contain the same genetic makeup as their placenta cells. 

Moriyah Naama and Moran Rahamim
Dr. Moriyah Naama (right) and Moran Rahamim. Courtesy of Moriyah Naama/Buganim Lab.

The project was led by Dr. Moriyah Naama, an MD/PhD program participant at the Hebrew University, in collaboration with Moran Rahamim, a PhD student, and other members of the Buganim lab.

“The findings of this study hold significant promise for advancing our understanding of pregnancy development, infertility, and pregnancy-related diseases,” the Hebrew University said in a statement.

“They have the potential to revolutionize research on placental pathologies and genetic causes, leading to improved diagnostic tools and therapeutic interventions.”

You have read 3 articles this month.
Register to receive full access to JNS.

Just before you scroll on...

Israel is at war. JNS is combating the stream of misinformation on Israel with real, honest and factual reporting. In order to deliver this in-depth, unbiased coverage of Israel and the Jewish world, we rely on readers like you. The support you provide allows our journalists to deliver the truth, free from bias and hidden agendas. Can we count on your support? Every contribution, big or small, helps JNS.org remain a trusted source of news you can rely on.

Become a part of our mission by donating today
Thank you. You are a loyal JNS Reader.
You have read more than 10 articles this month.
Please register for full access to continue reading and post comments.
Never miss a thing
Get the best stories faster with JNS breaking news updates